Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aligos Therapeutics, Inc. | 105,840 | reported | 09 Mar 2026 | tx 39+4,443,121−1,127,308 |
| INTERMUNE INC | 0 | reported | 19 May 2008 | tx 29+167,956−98,704 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Mar 2026 | GRANT_AWARD | Aligos Therapeutics, Inc. | 105,840 | 0.00 USD | deriv |
| 16 Jul 2025 | GRANT_AWARD | Aligos Therapeutics, Inc. | 179,800 | 0.00 USD | deriv |
| 28 Feb 2025 | GRANT_AWARD | Aligos Therapeutics, Inc. | 140,103 | 0.00 USD | deriv |
| 04 Sept 2024 | GRANT_AWARD | Aligos Therapeutics, Inc. | 33,920 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | Aligos Therapeutics, Inc. | 965,435 | 0.00 USD | deriv |
| 28 Feb 2024 | GRANT_AWARD | Aligos Therapeutics, Inc. | 132,352 | 0.00 USD | deriv |
| 28 Feb 2024 | GRANT_AWARD | Aligos Therapeutics, Inc. | 230,999 | 0.00 USD | deriv |
| 28 Feb 2024 | GRANT_AWARD | Aligos Therapeutics, Inc. | 57,749 | 0.00 USD | deriv |
| 27 Feb 2024 | OTHER | Aligos Therapeutics, Inc. | 323,400 | 0.00 USD | deriv |
| 27 Feb 2024 | OTHER | Aligos Therapeutics, Inc. | 450,000 | 0.00 USD | deriv |
| 27 Feb 2024 | OTHER | Aligos Therapeutics, Inc. | 80,850 | 0.00 USD | deriv |
| 25 Oct 2023 | GRANT_AWARD | Aligos Therapeutics, Inc. | 610,277 | 0.76 USD | |
| 25 Oct 2023 | GRANT_AWARD | Aligos Therapeutics, Inc. | 305,138 | 0.13 USD | deriv |
| 08 Sept 2023 | GRANT_AWARD | Aligos Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |
| 15 Mar 2023 | GRANT_AWARD | Aligos Therapeutics, Inc. | 242,500 | 0.00 USD | deriv |
| 07 Jul 2022 | GRANT_AWARD | Aligos Therapeutics, Inc. | 161,700 | 0.00 USD | deriv |
| 04 Feb 2022 | GRANT_AWARD | Aligos Therapeutics, Inc. | 323,400 | 0.00 USD | deriv |
| 04 Feb 2022 | GRANT_AWARD | Aligos Therapeutics, Inc. | 80,850 | 0.00 USD | deriv |
| 01 Dec 2020 | GRANT_AWARD | Aligos Therapeutics, Inc. | 450,000 | 0.00 USD | deriv |
| 20 Oct 2020 | CONVERSION | Aligos Therapeutics, Inc. | 1,452 | — | |
| 20 Oct 2020 | CONVERSION | Aligos Therapeutics, Inc. | 21,695 | — | |
| 20 Oct 2020 | CONVERSION | Aligos Therapeutics, Inc. | 3,394 | — | |
| 20 Oct 2020 | CONVERSION | Aligos Therapeutics, Inc. | 1,452 | — | |
| 20 Oct 2020 | CONVERSION | Aligos Therapeutics, Inc. | 3,394 | — | |
| 20 Oct 2020 | CONVERSION | Aligos Therapeutics, Inc. | 122,601 | — |